Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer

[1]  S. Ropero,et al.  Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile. , 2016, The Journal of urology.

[2]  O. Sheils,et al.  Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones , 2015, Journal of Clinical Pathology.

[3]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[4]  T. Lumley,et al.  ADAM19 and HTR4 Variants and Pulmonary Function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study , 2014, Circulation. Cardiovascular genetics.

[5]  R. Gibbs,et al.  Sequencing of 2 Subclinical Atherosclerosis Candidate Regions in 3669 Individuals: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study , 2014, Circulation. Cardiovascular genetics.

[6]  T. Macdonald,et al.  High Expression of the “A Disintegrin And Metalloprotease” 19 (ADAM19), a Sheddase for TNF-&agr; in the Mucosa of Patients with Inflammatory Bowel Diseases , 2013, Inflammatory bowel diseases.

[7]  Li Dong Wang,et al.  The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma. , 2012, Cancer letters.

[8]  Wei Liu,et al.  ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. , 2011, International journal of oncology.

[9]  E. Zabarovsky,et al.  Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-κB–mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis , 2011, Proceedings of the National Academy of Sciences.

[10]  C. Hsieh,et al.  Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy , 2011, The Prostate.

[11]  E. Futai,et al.  ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2. , 2010, Biochemical and biophysical research communications.

[12]  P. Foubert,et al.  Integrin α4β1 signaling is required for lymphangiogenesis and tumor metastasis (Cancer Research (2010) 70, (3042-51) DOI , 2010 .

[13]  Q. Sang,et al.  ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. , 2009, Current pharmaceutical design.

[14]  Sakae Tanaka,et al.  Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha. , 2009, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[15]  C. Pilarsky,et al.  ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. , 2008, European urology.

[16]  Huaxia Qin,et al.  Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. , 2008, Neoplasia.

[17]  R. Chari.  Targeted cancer therapy: conferring specificity to cytotoxic drugs. , 2008, Accounts of chemical research.

[18]  S. Tatarano,et al.  Nuclear translocation of ADAM‐10 contributes to the pathogenesis and progression of human prostate cancer , 2007, Cancer science.

[19]  G. D. De Keulenaer,et al.  Role of Neuregulin-1/ErbB Signaling in Cardiovascular Physiology and Disease: Implications for Therapy of Heart Failure , 2007, Circulation.

[20]  C. Liang,et al.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.

[21]  H. van Goor,et al.  ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration. , 2006, Kidney international.

[22]  D. Sheppard,et al.  ADAM33 Is Not Essential for Growth and Development and Does Not Modulate Allergic Asthma in Mice , 2006, Molecular and Cellular Biology.

[23]  D. Wildeboer,et al.  Metalloproteinase Disintegrins ADAM8 and ADAM19 Are Highly Regulated in Human Primary Brain Tumors and their Expression Levels and Activities Are Associated with Invasiveness , 2006, Journal of neuropathology and experimental neurology.

[24]  S. Varambally,et al.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. , 2006, Neoplasia.

[25]  P. Chumakov,et al.  Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP , 2005, Oncogene.

[26]  Judith M. White,et al.  Selective modulation of integrin-mediated cell migration by distinct ADAM family members. , 2005, Molecular biology of the cell.

[27]  M. Pelto-huikko,et al.  Shedding light on ADAM metalloproteinases. , 2005, Trends in biochemical sciences.

[28]  N. LeBrasseur,et al.  The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training , 2005, European Journal of Applied Physiology.

[29]  A. Sehara-Fujisawa,et al.  Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin β/ADAM19 , 2004, Journal of neurochemistry.

[30]  Y. Nabeshima,et al.  Essential roles of Meltrin β (ADAM19) in heart development , 2004 .

[31]  M. Grzmil,et al.  Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up‐regulates IGF binding protein‐3, and suppresses MMP‐2 expression , 2004, The Journal of pathology.

[32]  K. Horiuchi,et al.  Essential Role for ADAM19 in Cardiovascular Morphogenesis , 2004, Molecular and Cellular Biology.

[33]  C. Blobel,et al.  Catalytic Properties of ADAM19* , 2003, Journal of Biological Chemistry.

[34]  C. Higano.  Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. , 2003, Urology.

[35]  Xiaoli Shen,et al.  PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile , 2003, Molecular and Cellular Endocrinology.

[36]  T. Kang,et al.  Autolytic Processing at Glu586-Ser587within the Cysteine-rich Domain of Human Adamalysin 19/Disintegrin-Metalloproteinase 19 Is Necessary for Its Proteolytic Activity* , 2002, The Journal of Biological Chemistry.

[37]  P. Wei,et al.  Inhibitory antibodies against endopeptidase activity of human adamalysin 19. , 2001, Biochemical and biophysical research communications.

[38]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[39]  S. Wakatsuki,et al.  Roles of Meltrin β/ADAM19 in the Processing of Neuregulin* , 2001, The Journal of Biological Chemistry.

[40]  S. Ruben,et al.  Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. , 2001, Biochemical and biophysical research communications.

[41]  S. Rose-John,et al.  Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. , 2000, European journal of biochemistry.

[42]  E. Giovannucci.  Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Cancer , 1999, Hormone Research in Paediatrics.

[43]  Y. Nabeshima,et al.  Spatially- and temporally-restricted expression of meltrin α (ADAM12) and β (ADAM19) in mouse embryo , 1998, Mechanisms of Development.

[44]  G. Weskamp,et al.  Cloning and Initial Characterization of Mouse Meltrin β and Analysis of the Expression of Four MetalloproteaseDisintegrins in Bone Cells* , 1998, The Journal of Biological Chemistry.

[45]  J. Rhim,et al.  ErbB kinases and NDF signaling in human prostate cancer cells , 1997, Oncogene.

[46]  M. Kattan,et al.  Androgen-independent prostate cancer progression in the TRAMP model. , 1997, Cancer research.

[47]  N. Niikawa,et al.  Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3. , 1996, Genomics.

[48]  H. Pitt,et al.  Radiation and Chemotherapy , 2013 .

[49]  R. Mattingly,et al.  TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines , 2004 .

[50]  Y. Nabeshima,et al.  Gene expression pattern Spatially- and temporally-restricted expression of meltrin a (ADAM12) and b (ADAM19) in mouse embryo , 1998 .